Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Acorda Therapeutics, Inc. (NQ: ACOR)
32.67 USD  +0.44 (+1.37%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Acorda Therapeutics, Inc.
 
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriter
August 19, 2008
from Business Wire News Releases
BellwetherReport.com Analyst Report on ACOR, CTRN, ARMH and ILMN
August 07, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
Acorda Therapeutics, Inc. Announces Pricing of Common Stock Offering
August 07, 2008
from Business Wire News Releases
Acorda Therapeutics Reports Second Quarter 2008 Financial Results
August 05, 2008
from Business Wire News Releases
Acorda Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
August 04, 2008
from Business Wire News Releases
Acorda Therapeutics Presents Positive Data from Preclinical Studies of Neuregulins in Cardiac Function
July 30, 2008
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report Second Quarter 2008 Financial Results on August 5, 2008
July 29, 2008
from Business Wire News Releases
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organization (BIO)
June 20, 2008
-- Also Named Vice Chair of Emerging Companies Section -- Read More
from Business Wire News Releases
Zacks Bull and Bear of the Day Highlights: Coca-Cola FEMSA, Acorda Therapeutics, XTO Energy, SiRF Technology and Hallmark Financial Services
June 05, 2008
from Business Wire News Releases
Market Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN ? NACEL Energy Achieves Objectives With 640 MW Wind Power in Development, Sets New 1000 MW Target and Prepares for Rapid Expansion!
June 03, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse. Read More
from Marketwired News Releases
Equity Spotlight for Tuesday, June 03, 2008: NPHS Best Performance!
June 03, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc. Read More
from Marketwired News Releases
BellwetherReport.com Analyst Report on ACOR, CNXT, PPHM and ABMD
June 02, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
Acorda Therapeutics Announces Positive Data from Second Phase 3 Study of Fampridine-SR on Walking Ability in People with Multiple Sclerosis
June 02, 2008
Company Plans to File New Drug Application (NDA) in First Quarter of 2009 Investor Conference Call and Webcast Today at 8:30 A.M. ET Read More
from Business Wire News Releases
Acorda Therapeutics Reports First Quarter 2008 Financial Results
May 05, 2008
from Business Wire News Releases
Acorda Therapeutics to Present at Two Upcoming Conferences
May 02, 2008
from Business Wire News Releases
Acorda Therapeutics to Present at the Deutsche Bank 33rd Annual Health Care Conference
April 29, 2008
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report First Quarter 2008 Financial Results on May 5, 2008
April 23, 2008
from Business Wire News Releases
Acorda Therapeutics to Host Analyst and Investor Breakfast
April 09, 2008
from Business Wire News Releases
Acorda Therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOS
April 09, 2008
from Business Wire News Releases
Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing
April 03, 2008
from Business Wire News Releases
Loss of Mobility Found to Impact Quality of Life and Emotional and Financial Health of Most People Living with Multiple Sclerosis
March 25, 2008
Two new complementary surveys provide groundbreaking data on the impact of walking impairment on people living with multiple sclerosis, revealing challenges related to quality of life, family... Read More
from Business Wire News Releases
Acorda Therapeutics to Present at the Cowen and Company 28th Annual Health Care Conference
March 10, 2008
from Business Wire News Releases
Acorda Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
February 13, 2008
from Business Wire News Releases
Acorda Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results
February 11, 2008
-- Lead clinical product, Fampridine-SR, entered and completed enrollment for second Phase 3 clinical trial in multiple sclerosis (MS); data expected in the latter part of Q2 08 -- Zanaflex Capsules(R)... Read More
from Business Wire News Releases
Acorda Therapeutics Reschedules Fourth Quarter and Year End 2007 Financial Results to February 11, 2008
February 07, 2008
from Business Wire News Releases
Acorda Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
February 06, 2008
from Business Wire News Releases
Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre-Clinical Assets from Neurorecovery, Inc.
February 04, 2008
from Business Wire News Releases
Wall Street News Alert: Stocks to Watch This Tuesday Morning: ERUC! January 29, 2008
January 29, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding Read More
from Marketwired News Releases
Acorda Therapeutics Announces Successful Thorough QT Study of Fampridine-SR
January 28, 2008
Fampridine-SR Not Associated with QT Changes Company to Host Conference Call at 8:30 am Eastern Time Today Read More
from Business Wire News Releases
Saatchi & Saatchi Consumer Health+Wellness Wins Third New Business Pitch in Six Months
January 16, 2008
Proving Validity of Agency's New Direction Read More
from Business Wire News Releases
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here